Wei East Inc. – Trademark Portfolio

Entity Type: 03

Wei East Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include WEI, WEI EAST, CHINA HERBAL, and CHINA HERBAL BEAUTY. The owner is based in Newtown Square, PA.

4107 Goshen Road

Newtown Square, PA 19073

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Wei East Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (10 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Wei East Inc. have?

Wei East Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned, 5 cancelled.

What trademark classes does Wei East Inc. file in?

Wei East Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Wei East Inc.'s most well-known trademarks?

Wei East Inc.'s registered trademark portfolio includes well-known marks such as WEI, WEI EAST, CHINA HERBAL, and CHINA HERBAL BEAUTY. These are among 4 currently registered trademarks in the portfolio.

What is Wei East Inc.'s trademark registration success rate?

Wei East Inc. has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.